Conneqt Health Limited (CQT) - Net Assets
Based on the latest financial reports, Conneqt Health Limited (CQT) has net assets worth AU$-2.46 Million AUD (≈ $-1.74 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$7.86 Million ≈ $5.56 Million USD) and total liabilities (AU$10.31 Million ≈ $7.30 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how strategically is Conneqt Health Limited's equity deployed to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$-2.46 Million |
| % of Total Assets | -31.27% |
| Annual Growth Rate | -46.8% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 39.94 |
Conneqt Health Limited - Net Assets Trend (2021–2025)
This chart illustrates how Conneqt Health Limited's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see CQT stock market capitalisation.
Annual Net Assets for Conneqt Health Limited (2021–2025)
The table below shows the annual net assets of Conneqt Health Limited from 2021 to 2025. Also explore net asset momentum of Conneqt Health Limited to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | AU$633.50K ≈ $448.24K |
-84.50% |
| 2024-06-30 | AU$4.09 Million ≈ $2.89 Million |
+646.16% |
| 2023-06-30 | AU$-748.40K ≈ $-529.54K |
-111.32% |
| 2022-06-30 | AU$6.61 Million ≈ $4.68 Million |
-16.42% |
| 2021-06-30 | AU$7.91 Million ≈ $5.60 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Conneqt Health Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4779419100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$102.89 Million | 16241.27% |
| Total Equity | AU$633.51K | 100.00% |
Conneqt Health Limited Competitors by Market Cap
The table below lists competitors of Conneqt Health Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Charan Insurance Public Company Limited
BK:CHARAN
|
$7.74 Million |
|
Bergenbio ASA
OL:BGBIO
|
$7.75 Million |
|
Global Interactive Technologies, Inc
NASDAQ:GITS
|
$7.75 Million |
|
KWESST MICRO SYS.INC.
F:62UA
|
$7.75 Million |
|
T3 Defense Inc.
NASDAQ:DFNS
|
$7.74 Million |
|
Paras Petrofils Limited
NSE:PARASPETRO
|
$7.73 Million |
|
Birks Group Inc
NYSE MKT:BGI
|
$7.72 Million |
|
Identi Healthcare Ltd
TA:IDNT
|
$7.71 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Conneqt Health Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 4,087,480 to 633,510, a change of -3,453,970 (-84.5%).
- Net loss of 18,193,980 reduced equity.
- Share repurchases of 8,547,140 reduced equity.
- Other factors increased equity by 23,287,150.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-18.19 Million | -2871.93% |
| Share Repurchases | AU$8.55 Million | -1349.17% |
| Other Changes | AU$23.29 Million | +3675.89% |
| Total Change | AU$- | -84.50% |
Book Value vs Market Value Analysis
This analysis compares Conneqt Health Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 14.76x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.23x to 14.76x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-06-30 | AU$0.07 | AU$0.02 | x |
| 2022-06-30 | AU$0.05 | AU$0.02 | x |
| 2023-06-30 | AU$0.00 | AU$0.02 | x |
| 2024-06-30 | AU$0.01 | AU$0.02 | x |
| 2025-06-30 | AU$0.00 | AU$0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Conneqt Health Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -2871.93%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -511.88%
- • Asset Turnover: 0.38x
- • Equity Multiplier: 14.72x
- Recent ROE (-2871.93%) is below the historical average (-804.02%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | -178.63% | -290.38% | 0.33x | 1.87x | AU$-12.47 Million |
| 2023 | 0.00% | -388.47% | 0.33x | 0.00x | AU$-18.81 Million |
| 2024 | -165.51% | -60.53% | 0.88x | 3.09x | AU$-7.17 Million |
| 2025 | -2871.93% | -511.88% | 0.38x | 14.72x | AU$-18.26 Million |
Industry Comparison
This section compares Conneqt Health Limited's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $40,109,748
- Average return on equity (ROE) among peers: -41.94%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Conneqt Health Limited (CQT) | AU$-2.46 Million | -178.63% | N/A | $7.74 Million |
| 4DMEDICAL Ltd (4DX) | $3.78 Million | -104.20% | 0.44x | $1.75 Billion |
| Adherium Ltd (ADR) | $-4.76 Million | 0.00% | 0.00x | $3.18 Million |
| Aroa Biosurgery Ltd (ARX) | $1.81 Million | 0.00% | 6.66x | $130.04 Million |
| Atomo Diagnostics Ltd (AT1) | $10.08 Million | -67.90% | 0.13x | $11.49 Million |
| Avita Medical Inc (AVH) | $3.98 Million | -125.89% | 0.98x | $188.51 Million |
| Anteris Technologies Global Corp (AVR) | $13.64 Million | -10.42% | 0.08x | $809.31 Million |
| Control Bionics Ltd (CBL) | $6.09 Million | -15.97% | 0.04x | $23.82 Million |
| Cardiex Ltd (CDX) | $1.88 Million | -105.36% | 1.22x | $13.23 Million |
| Compumedics Ltd (CMP) | $9.21 Million | -30.70% | 1.16x | $33.22 Million |
| Cochlear Ltd (COH) | $355.39 Million | 41.04% | 1.46x | $6.20 Billion |
About Conneqt Health Limited
Conneqt Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffnes… Read more